Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, The 9# Jin Sui Road, Guangzhou, Guangdong 510623, China.
Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, The 9# Jin Sui Road, Guangzhou, Guangdong 510623, China.
Mult Scler Relat Disord. 2020 Jul;42:102018. doi: 10.1016/j.msard.2020.102018. Epub 2020 Feb 22.
To analyze the clinical features in children with anti-NMDAR encephalitis combined with myelin oligodendrocyte glycoprotein antibody (MOG ab).
Clinical data of 7 children with anti-NMDAR encephalitis combined with MOG ab(+) were collected in Guangzhou Women and Children's Medical Center from January, 2016 to June, 2019. Children with NMDAR ab(+)/MOG ab(-) and MOG ab(+)/NMDAR ab(-) were randomly selected as controls.
Onset age was 6.0 (IQR 5.0-7.0) years old, male to female was 2:5. Prominent symptoms include abnormal mental behavior (7/7), sleep disorder (6/7), speech disorder (6/7), involuntary movement (4/7) and paralysis (4/7). There were significant differences between NMDAR ab(+)/MOG ab(+) group versus MOG ab(+)/NMDAR ab(-) and NMDAR ab(+)/MOG ab(-) group versus MOG ab(+)/NMDAR ab(-) group (P< 0.0167, Fisher exact tests) in abnormal mental behavior, sleep disorder, speech disorder and involuntary movement. 1 case developed anti-NMDAR encephalitis 1 year after recovery from MOG ab related acute disseminated encephalomyelitis (ADEM). 4 cases developed anti-NMDAR encephalitis and MOG ab related ADEM simultaneously, with 2 cases relapsed. 2 cases were anti-NMDAR encephalitis with only MOG ab positive. In terms of MRI, there were differences in subcortical white matter, basal ganglia and brainstem (P < 0.0167, Fisher exact tests) between NMDAR ab(+)/MOG ab(+) group versus NMDAR ab(+)/MOG ab(-) (P < 0.0001) and NMDAR ab(+)/MOG ab(-) group versus MOG ab(+)/NMDAR ab(-) group(P<0.0001). There were significant differences in MOG antibody titer (Z = -=2.03, P = 0.042) and duration (Z = -1.97, P = 0.049) between relapsed and non-relapsed patients. 3 cases had neurological sequelae. The differences of NMDAR antibody titer (Z = -2.22, P = 0.026) and duration (Z = -2.18, P = 0.029) were significant between patients with and without neurological sequelae.
NMDAR and MOG antibodies can coexist in children with autoimmune encephalitis. Double antibody positive subjects had more overlaps in clinical manifestations with NMDAR encephalitis, and more overlaps in MRI changes with MOG ab related disease. Higher persistent MOG antibody titer may indicate recurrence, while higher persistent NMDAR antibodies titer may cause neurological sequelae.
分析抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎合并髓鞘少突胶质细胞糖蛋白抗体(MOG ab)阳性患儿的临床特征。
收集 2016 年 1 月至 2019 年 6 月在广州市妇女儿童医疗中心确诊的 7 例抗 NMDAR 脑炎合并 MOG ab(+)患儿的临床资料,随机选择抗 NMDAR ab(+)/MOG ab(-)和 MOG ab(+)/NMDAR ab(-)患儿作为对照。
患儿发病年龄为 6.0(IQR 5.0-7.0)岁,男∶女为 2∶5。主要表现为精神行为异常(7/7)、睡眠障碍(6/7)、言语障碍(6/7)、不自主运动(4/7)和瘫痪(4/7)。抗 NMDAR ab(+)/MOG ab(+)组与 MOG ab(+)/NMDAR ab(-)组、抗 NMDAR ab(+)/MOG ab(-)组与 MOG ab(+)/NMDAR ab(-)组相比,精神行为异常、睡眠障碍、言语障碍和不自主运动发生率差异均有统计学意义(P 值均<0.0167,Fisher 确切概率法)。1 例在 MO G ab 相关急性播散性脑脊髓炎(ADEM)痊愈后 1 年发生抗 NMDAR 脑炎,4 例同时发生抗 NMDAR 脑炎和 MOG ab 相关 ADEM,其中 2 例复发,2 例仅为抗 NMDAR 脑炎且 MOG ab 阳性。MRI 结果显示,抗 NMDAR ab(+)/MOG ab(+)组与抗 NMDAR ab(+)/MOG ab(-)组(P<0.0167)、抗 NMDAR ab(+)/MOG ab(-)组与 MOG ab(+)/NMDAR ab(-)组(P<0.0001)在皮质下白质、基底节和脑干方面存在差异。MOG 抗体滴度(Z=-2.03,P=0.042)和持续时间(Z=-1.97,P=0.049)在复发与非复发患儿之间存在差异。3 例患儿遗留神经系统后遗症。NMDAR 抗体滴度(Z=-2.22,P=0.026)和持续时间(Z=-2.18,P=0.029)在有神经系统后遗症和无神经系统后遗症患儿之间存在差异。
NMDAR 和 MOG 抗体可同时存在于自身免疫性脑炎患儿中。双抗体阳性患儿的临床表现与 NMDAR 脑炎重叠更多,MRI 改变与 MOG ab 相关疾病重叠更多。持续存在的 MOG 抗体滴度较高可能预示复发,而持续存在的 NMDAR 抗体滴度较高可能导致神经系统后遗症。